No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs115371361 |
chr1:161888028-161888029 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs527974721 |
chr1:161888083-161888084 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs147305784 |
chr1:161888253-161888254 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs17416633 |
chr1:161888269-161888270 |
Weak transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
5 |
rs533534167 |
chr1:161888350-161888351 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs552007688 |
chr1:161888360-161888361 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs568950849 |
chr1:161888361-161888362 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs537873859 |
chr1:161888390-161888391 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs191370942 |
chr1:161888397-161888398 |
Weak transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs61809463 |
chr1:161888439-161888440 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs532677177 |
chr1:161888457-161888458 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs568411497 |
chr1:161888479-161888480 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs552617365 |
chr1:161888517-161888518 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs140875459 |
chr1:161888569-161888570 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs553994241 |
chr1:161888609-161888610 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs576983626 |
chr1:161888664-161888665 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs116228974 |
chr1:161888750-161888751 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs142755308 |
chr1:161888802-161888803 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs184319840 |
chr1:161888818-161888819 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs541865576 |
chr1:161888852-161888853 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs561747532 |
chr1:161888853-161888854 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs572065941 |
chr1:161888865-161888866 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
23 |
rs541374579 |
chr1:161888891-161888892 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs371059508 |
chr1:161888909-161888910 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs188665401 |
chr1:161888931-161888932 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs536892036 |
chr1:161888937-161888938 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs4417044 |
chr1:161888955-161888956 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
28 |
rs181118411 |
chr1:161889126-161889127 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs550331366 |
chr1:161889137-161889138 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs187028283 |
chr1:161889179-161889180 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs531431471 |
chr1:161889185-161889186 |
Weak transcription Flanking Active TSS Enhancers Active TSS Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs144514614 |
chr1:161889220-161889221 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs148427979 |
chr1:161889282-161889283 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs533748116 |
chr1:161889326-161889327 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs142524493 |
chr1:161889349-161889350 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs570705849 |
chr1:161889364-161889365 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs539291393 |
chr1:161889394-161889395 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs112861167 |
chr1:161889472-161889473 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs555932310 |
chr1:161889533-161889534 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs575782693 |
chr1:161889538-161889539 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs574503630 |
chr1:161889581-161889582 |
Weak transcription Flanking Active TSS Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs189871509 |
chr1:161889658-161889659 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs555403553 |
chr1:161889688-161889689 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs139979051 |
chr1:161889689-161889690 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs549410772 |
chr1:161889700-161889701 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs564659671 |
chr1:161889721-161889722 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs143453731 |
chr1:161889771-161889772 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs374789366 |
chr1:161889818-161889819 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs563876427 |
chr1:161889821-161889822 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs535493356 |
chr1:161889826-161889827 |
Weak transcription Enhancers Strong transcription
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|